PRP guidelines · International

Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial

Yung-Tsan Wu, Tsung-Yen Ho, Yu-Ching Chou, Ming-Jen Ke, Tsung-Ying Li, Guo-Shu Huang, Liang-Cheng Che

Scientific Reports · 2017

In brief

People with mild to moderate carpal tunnel syndrome were randomised to a single ultrasound-guided platelet-rich plasma (PRP) injection or to wearing a night splint. At six months, the authors report less pain, better symptom and function scores and reduced nerve swelling in the PRP group, and describe PRP as safe in this setting.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial Authors: Yung-Tsan Wu, Tsung-Yen Ho, Yu-Ching Chou, Ming-Jen Ke, Tsung-Ying Li, Guo-Shu Huang, Liang-Cheng Che Link: https://pubmed.ncbi.nlm.nih.gov/28273894/ Year of Publication: 2017

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.